Acuson of Mountain View, CA, announced that company president and director Daniel Dugan resigned effective March 1. Former Acuson president Robert Gallagher will come out of retirement to serve as president and chief operating officer until sometime in
Acuson of Mountain View, CA, announced that company president and director Daniel Dugan resigned effective March 1. Former Acuson president Robert Gallagher will come out of retirement to serve as president and chief operating officer until sometime in June, when a permanent replacement for Dugan will be named. Gallagher, 56, previously was president and chief operating officer.
Dugan, 45, has been with Acuson for many years. He held senior sales management positions with the company from 1984 to 1989, then returned in 1991 as vice president of field operations after spending two years at Toshiba America Medical Systems as vice president of U.S. ultrasound business operations. Dugan was made vice president of worldwide sales and field operations for Acuson in 1993, and senior vice president of worldwide sales, service, and marketing in March 1994. He was promoted to president in November 1997.
Dugans departure appears to be unrelated to the companys financial performance. In fact, the company is coming off its most successful year ever and record fourth-quarter revenues. The ultrasound vendor posted revenues of $135 million for the fourth quarter of 1999, an increase of 10% compared with the fourth quarter of 1998, and $475.9 million for the year, compared to $455 million in 1998. Excluding a one-time $13.9 million after-tax write-off associated with the December 1999 acquisition of Ecton, the company reported net income of $6.8 million in the fourth quarter of 1998. Including the write-off, Acuson reported a net loss for the quarter of $7.1 million.
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.